Product logins

Find logins to all Clarivate products below.


Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific | 2021

Following the initial impact of the COVID-19 pandemic, the Asia Pacific market for TEO devices will expand at a strong rate, driven by adoption of innovative and premium-priced products, incremental device improvements, as well as rising penetration of endovascular embolization in new indications.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for TEO devices in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Latin America
The Latin American TEO device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…